Loading clinical trials...
Loading clinical trials...
The primary objective of this study was to establish the bioequivalence of two different tablet formulations containing BAY77-1931. The secondary objectives of this study were to assess the safety and...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bayer
NCT02276274 · Clinical Pharmacology
NCT01473108 · Clinical Pharmacology
NCT04511611 · Clinical Pharmacology
NCT04366622 · Clinical Pharmacology
NCT03517930 · Clinical Pharmacology
Fukuoka, Fukuoka
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions